Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00301574
Status:
COMPLETED
Last Update Posted:
2011-05-17
First Post:
2006-03-10
Brief Title:
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimers Disease
Sponsor:
Janssen Pharmaceutical KK
Organization:
Janssen Pharmaceutical KK
Organization Data
Organization:
Janssen Pharmaceutical KK
Class:
INDUSTRY
Study ID:
CR003301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Pharmaceutical KK
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None